Windlas Biotech Limited (WINDLAS) — Net Asset Momentum

Latest YoY growth as of March 2025: +12.4%

Windlas Biotech Limited (WINDLAS) recorded a net asset momentum of 12.4% as of March 2025, with net assets of Rs5.06 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See WINDLAS cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

YoY Momentum

+12.4%
Year-over-year

Current Net Assets

Rs5.06 Billion
INR · March 2025

Years of Data

8
2018 – 2025

Country

India
NSE

Windlas Biotech Limited Net Asset Momentum (2018–2025)

This chart tracks Windlas Biotech Limited's year-over-year net asset growth across 8 annual reporting periods from 2018 to 2025. The most recent momentum reading is +12.4%, with net assets of Rs5.06 Billion INR as of March 2025. Read Windlas Biotech Limited (WINDLAS) total liabilities for a breakdown of total debt and financial obligations.

Annual Net Asset History for Windlas Biotech Limited (2018–2025)

The table below shows the complete annual net asset history for Windlas Biotech Limited from 2018 to 2025, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market cap of Windlas Biotech Limited.

Year Net Assets (INR) Total Assets Total Liabilities YoY Momentum
2025 Rs5.06 Billion Rs7.60 Billion Rs2.55 Billion ▲ +12.4%
2024 Rs4.50 Billion Rs6.26 Billion Rs1.76 Billion ▲ +11.8%
2023 Rs4.02 Billion Rs5.29 Billion Rs1.27 Billion ▲ +1.9%
2022 Rs3.95 Billion Rs4.91 Billion Rs962.33 Million ▲ +98.3%
2021 Rs1.99 Billion Rs2.96 Billion Rs970.04 Million ▼ -5.0%
2020 Rs2.10 Billion Rs3.38 Billion Rs1.29 Billion ▲ +8.3%
2019 Rs1.94 Billion Rs2.98 Billion Rs1.05 Billion ▲ +54.8%
2018 Rs1.25 Billion Rs2.90 Billion Rs1.65 Billion